Upregulation of miR-324-5p Inhibits Proliferation and Invasion of Colorectal Cancer Cells by Targeting ELAVL1

被引:56
作者
Gu, Chijiang [1 ]
Zhang, Mingyuan [1 ]
Sun, Weiliang [1 ]
Dong, Changzheng [2 ]
机构
[1] Ningbo Univ, Affiliated Yinzhou Hosp, Dept Gastrointestinal Surg, Baizhang East Rd 251, Ningbo 315000, Zhejiang, Peoples R China
[2] Ningbo Univ, Sch Med, Ningbo, Zhejiang, Peoples R China
关键词
Colorectal cancer (CRC); miR-324-5p; Proliferation; Invasion; (Embryonic lethal; abnormal vision; Drosophila)-like protein 1 (ELAVL1); PLASMINOGEN-ACTIVATOR; BINDING; HUR; OXALIPLATIN; LEUCOVORIN; IRINOTECAN; STABILITY;
D O I
10.3727/096504018X15166183598572
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Colorectal cancer (CRC) is a common clinical cancer that remains incurable in most cases. miRNAs are reported to play a part in the development of various tumors. In the present study, we found that miR-324-5p was downregulated in CRC cells, while ELAV (embryonic lethal, abnormal vision, Drosophila)-like protein 1 (ELAVL1) showed a higher expression. miR-324-5p transfection significantly inhibited the proliferation as well as invasion in both SW620 and SW480 cells. miR-324-5p mimic transfection markedly decreased the expression of ELAVL1. Luciferase reporter gene assay confirmed that ELAVL1 is a direct target of miR-324-5p. Furthermore, cancer invasion factors uPA, uPAR, and MMP-9 were found to drop significantly in miR-324-5p-transfected groups. To conclude, our findings indicate that miR-324-5p may play a suppressive role in colorectal cell viability and invasion, at least in part, through directly targeting ELAVL1. Therefore, miR-234-5p might function as a promising candidate for CRC treatment and deserves deeper research.
引用
收藏
页码:515 / 524
页数:10
相关论文
共 31 条
[1]
Posttranscriptional regulation of cancer traits by HuR [J].
Abdelmohsen, Kotb ;
Gorospe, Myriam .
WILEY INTERDISCIPLINARY REVIEWS-RNA, 2010, 1 (02) :214-229
[2]
Epigenetic and genetic features of 24 colon cancer cell lines [J].
Ahmed, D. ;
Eide, P. W. ;
Eilertsen, I. A. ;
Danielsen, S. A. ;
Eknaes, M. ;
Hektoen, M. ;
Lind, G. E. ;
Lothe, R. A. .
ONCOGENESIS, 2013, 2 :e71-e71
[3]
miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer [J].
Al-Ahmadi, Wijdan ;
Al-Ghamdi, Maha ;
Al-Souhibani, Norah ;
Khabar, Khalid S. A. .
JOURNAL OF PATHOLOGY, 2013, 230 (01) :28-38
[4]
The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[5]
Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis [J].
Blanco, Fernando F. ;
Preet, Ranjan ;
Aguado, Andrea ;
Vishwakarma, Vikalp ;
Stevens, Laura E. ;
Vyas, Alok ;
Padhye, Subhash ;
Xu, Liang ;
Weir, Scott J. ;
Anant, Shrikant ;
Meisner-Kober, Nicole ;
Brody, Jonathan R. ;
Dixon, Dan A. .
ONCOTARGET, 2016, 7 (45) :74043-74058
[6]
MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1 [J].
Cao, Liangqi ;
Xie, Binhui ;
Yang, Xuewei ;
Liang, Huihong ;
Jiang, Xiaofeng ;
Zhang, Dawei ;
Xue, Ping ;
Chen, De ;
Shao, Zili .
PLOS ONE, 2015, 10 (07)
[7]
First-line oral capecitabine therapy in metastatic colorectal cancer:: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin [J].
Cassidy, J ;
Twelves, C ;
Van Cutsem, E ;
Hoff, P ;
Bajetta, E ;
Boyer, M ;
Bugat, R ;
Burger, U ;
Garin, A ;
Graeven, U ;
McKendrick, J ;
Maroun, J ;
Marshall, J ;
Osterwalder, B ;
Pérez-Manga, G ;
Rosso, R ;
Rougier, P ;
Schilsky, RL .
ANNALS OF ONCOLOGY, 2002, 13 (04) :566-575
[8]
Dysregulation of the MiR-324-5p-CUEDC2 Axis Leads to Macrophage Dysfunction and Is Associated with Colon Cancer [J].
Chen, Yuan ;
Wang, Shao-Xin ;
Mu, Rui ;
Luo, Xue ;
Liu, Zhao-Shan ;
Liang, Bing ;
Zhuo, Hai-Long ;
Hao, Xiao-Peng ;
Wang, Qiong ;
Fang, Di-Feng ;
Bai, Zhao-Fang ;
Wang, Qian-Yi ;
Wang, He-Mei ;
Jin, Bao-Feng ;
Gong, Wei-Li ;
Zhou, Tao ;
Zhang, Xue-Min ;
Xia, Qing ;
Li, Tao .
CELL REPORTS, 2014, 7 (06) :1982-1993
[9]
MicroRNAs in Cancer [J].
Di Leva, Gianpiero ;
Garofalo, Michela ;
Croce, Carlo M. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9, 2014, 9 :287-314
[10]
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J].
Goldberg, RM ;
Sargent, DJ ;
Morton, RF ;
Fuchs, CS ;
Ramanathan, RK ;
Williamson, SK ;
Findlay, BP ;
Pitot, HC ;
Alberts, SR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :23-30